论文部分内容阅读
目的:观察分析甘精胰岛素与瑞格列奈联合治疗2型糖尿病临床效果。方法:选取我院从2011年3月～2012年3月收治的2型糖尿病患者共88例。对患者进行甘精胰岛素联合瑞格列奈的联合治疗,观察治疗前后患者的血糖变化。结果:患者治疗后的血糖水平均出现明显下降,并且基本恢复到正常水平。患者的空腹血糖治疗前后对比有显著性差异(P<0.01);餐后2小时的血糖水平以及糖化血红蛋白治疗前后对比也同样有显著性差异(P<0.01)。结论:甘精胰岛素与瑞格列奈联合治疗2型糖尿病能够有效降低患者血糖,取得良好的临床效果。
Objective: To observe and analyze the clinical effect of insulin glargine combined with repaglinide on type 2 diabetes mellitus. Methods: A total of 88 patients with type 2 diabetes admitted to our hospital from March 2011 to March 2012 were selected. Patients with glargine combined with repaglinide treatment, observation of patients before and after treatment of blood glucose changes. Results: After treatment, the patients’ blood glucose levels decreased obviously and returned to their normal levels. There was a significant difference between before and after treatment of fasting blood glucose (P <0.01). There was also significant difference in blood glucose level at two hours after meal and before and after HbA1c treatment (P <0.01). Conclusion: The combination of insulin glargine and repaglinide can effectively reduce the blood sugar in patients with type 2 diabetes and achieve good clinical results.